Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huang Jane
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bonita David P
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sandor Victor
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FRIEDMAN PAUL A
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dier Mardi
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Babler Martin
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lim Bryant David
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huang Jane
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Scherle Peggy
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lim Bryant David
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chardonnet Laurent
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Combs Andrew
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huang Jane
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vaddi Krishna
Prelude Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-UBS Group AG (for the benefit and on behalf of the UBS Asset(0%)
Prelude Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt, L.P.(9.85%),Deerfield Management Company, L.P.(9.85%), etc.
Prelude Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Krishna Vaddi(11.1%)
Prelude Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(0.630%),Abigail P. Johnson(0.630%)
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huang Jane
No Data